Skip to content
Bored Studies
RecruitingAccepts healthy volunteersPhase 4

Anterior Femoral and Adductor Canal Nerve Blocks in Peds Knees

Hospital for Special Surgery, New York · NCT06590402

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 8–18 · All sexes
Healthy volunteers
Accepted
Study type
Interventional · Phase 4
Target enrollment
60
US sites recruiting
1
Study start
June 6, 2025
Record last updated
October 13, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

The goal of this pilot clinical trial is to compare anterior femoral cutaneous nerve block (AFCN) to adductor canal block ACB) for pediatric patients undergoing either anterior cruciate ligament (ACL) or medial patellofemoral ligament (MPFL). The aims of this trial are:

  • To measure postoperative functional outcomes in patients who received AFCNB vs. ACB.
  • To calculate postoperative opioid requirements in pediatric knee surgeries that received AFCNB vs. ACB.
  • To calculate pain intensity levels at rest and with ambulation in patients who received AFCNB vs. ACB.
  • To quantify sensory deficits in patients who received AFCNB vs. ACB.
  • To assess patient-reported outcome measures (e.g., pain expectation scale, pain management satisfaction, PROMIS Pediatric Short Form v1.0 - Physical Activity, PROMIS Scale v1.2 - Global Health) in patients 8-18 years of age who received AFCNB vs. ACB.

Subjects undergoing ACL procedures will be compared between those who received the adductor canal block to those who received the anterior femoral cutaneous nerve block. The researchers will also compare individuals who underwent MPFL procedures and received an anterior femoral cutaneous nerve block with those who received the adductor canal block.

Participants will

  • Be randomized to receive either the AFCNB or ACB in addition to standard of care analgesia.
  • Maintain a patient diary to document daily pain meds/pain scores
  • Complete follow up surveys/questionnaires via telephone and during their office visits with surgeons.

Being studied: Bupivacaine, Dexamethasone in Adductor Canal Block; Bupivacaine, Dexamethasone in Anterior Femoral Cutaneous Nerve Block

Conditions: Anterior Cruciate Ligament Reconstruction; Medial Patellofemoral Ligament Reconstruction

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • 8-18 years old at the time of surgery
  • Patients 40kg and above
  • ACL reconstruction of MPFL reconstruction surgery with participating surgeons

Exclusion Criteria

  • revision surgery
  • bilateral surgery
  • general anesthesia
  • contraindications to any part of the study protocol
  • relevant pre-existing neurological deficit
  • chronic pain

Recruiting US locations

  • Hospital for Special Surgery

    New York, NY 10021

    Site contact: Jashvant Poeran, MD/PhD · poeranj@hss.edu

Study contacts (from the official record)

  • Marko Popovic · 646-797-8948 · popovicm@hss.edu
  • Alex Sideris, PhD · 212-774-2602 · Siderisa@hss.edu
All healthy volunteers studies in New York →
Anterior Femoral and Adductor Canal Nerve Blocks in Peds Knees (NCT06590402) | Bored Studies